data_6b3u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6b3u _Structure_validation_residue.Date_analyzed 2018-01-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.711 0.291 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 684' ' ' ILE . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 684' ' ' ILE . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.818 0.342 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . 0.411 HD13 HG22 ' A' ' 684' ' ' ILE . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 686' ' ' ILE . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.795 0.331 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 684' ' ' ILE . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 688' ' ' ILE . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.809 0.338 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.655 0.264 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.826 0.346 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.697 0.284 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 687' ' ' ILE . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 688' ' ' ILE . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.734 0.302 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.817 0.342 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.524 -0.023 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.58 -48.01 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.53 -33.18 44.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 684' ' ' ILE . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -70.08 -37.97 75.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 55.4 35.63 25.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.78 -39.5 97.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -147.56 160.13 42.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 56.1 m -81.16 123.38 81.76 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.395 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.8 145.09 97.67 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.982 1.788 . . . . 0.0 112.178 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.95 -39.49 92.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.517 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -66.91 -40.9 87.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.26 -42.03 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.626 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 684' ' ' ILE . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 -67.69 -34.1 76.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -161.58 98.18 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.29 99.54 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -67.95 131.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.289 . . . . 0.0 110.788 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 91.7 p -140.12 160.19 61.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.97 145.53 97.11 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.823 2.349 . . . . 0.0 112.42 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 tp -107.47 122.7 47.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.161 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -71.27 -35.23 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.543 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt -51.5 -33.57 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.577 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . 0.411 HD13 HG22 ' A' ' 684' ' ' ILE . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 686' ' ' ILE . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -65.57 -32.26 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 54.26 61.88 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -155.84 177.25 33.04 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 54.42 39.71 31.22 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.8 m -59.28 -44.88 98.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.68 137.98 79.8 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.875 1.717 . . . . 0.0 113.771 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 8.1 mp 40.48 57.27 2.58 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.281 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.673 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 15.2 p30 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -75.63 -38.82 58.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.529 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.56 -41.03 28.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 684' ' ' ILE . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 688' ' ' ILE . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -64.79 -36.52 84.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 54.12 84.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.482 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 59.32 -132.44 52.0 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.837 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -110.3 21.46 16.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.763 -0.219 . . . . 0.0 111.261 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 22.1 t -127.41 73.57 77.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.63 61.64 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.323 2.682 . . . . 0.0 112.062 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 9.2 mp -101.51 139.34 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 40.3 t-105 -55.27 -32.2 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.07 -43.08 68.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -62.45 -37.7 86.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.33 136.36 49.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 65.6 -171.15 26.16 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 54.09 -88.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.4 t 51.19 67.48 4.22 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.04 145.88 97.36 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.706 2.271 . . . . 0.0 112.054 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 136.39 48.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.537 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.98 -45.88 69.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.472 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp -56.27 -37.07 69.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -65.45 -39.78 92.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -154.25 120.96 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.578 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.4 97.03 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . 0.428 ' CZ ' ' HD2' ' A' ' 714' ' ' PRO . 93.4 t80 -126.68 114.01 17.44 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.307 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 714' ' ' PRO . 34.7 t -151.23 39.3 0.17 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 712' ' ' TYR . 36.3 Cg_exo -60.36 137.46 74.65 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 CA-C-N 121.701 1.643 . . . . 0.0 110.456 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.1 mt -126.9 140.8 52.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.466 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.603 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -67.08 -43.78 81.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.584 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.05 -41.98 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.57 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -71.96 116.25 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.48 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -97.17 -21.84 19.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -155.8 156.92 35.61 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.588 0.232 . . . . 0.0 110.498 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.3 m -104.62 -62.26 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.284 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.66 158.46 28.36 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.949 1.766 . . . . 0.0 111.157 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 64.7 tp -101.92 121.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.677 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.52 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -53.69 -28.85 35.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.78 -42.67 57.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.616 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -70.64 -31.57 68.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -54.82 134.02 47.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 57.37 -132.21 52.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -148.97 158.86 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 72.4 m -78.27 147.61 72.91 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.999 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.53 -36.88 98.58 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.227 1.951 . . . . 0.0 112.109 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.67 -43.97 97.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.783 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.553 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -72.95 -29.33 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp -55.56 -35.27 65.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 687' ' ' ILE . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 688' ' ' ILE . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.25 -28.8 57.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -67.54 109.78 3.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -82.33 178.81 53.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -150.23 160.67 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 9.5 t 48.19 61.87 13.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.16 68.62 8.25 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.247 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.22 164.79 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.577 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -73.81 -37.35 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.456 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.32 -36.85 66.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.619 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -59.57 -40.1 86.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.32 118.24 6.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -110.46 17.7 28.26 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -146.2 161.54 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.2 t 51.54 61.65 12.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 153.67 57.66 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.861 2.374 . . . . 0.0 112.267 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.76 -39.51 94.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.595 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -71.59 -26.04 62.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.06 -41.41 61.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -64.45 -40.71 96.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 59.97 29.18 18.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 53.65 -127.23 36.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.551 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.42 141.17 51.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.049 0.452 . . . . 0.0 111.198 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 58.2 p -141.04 72.45 27.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.89 -68.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.464 2.109 . . . . 0.0 112.859 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 63.2 tp -142.31 128.94 20.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.538 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.444 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -61.06 -34.0 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.584 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.73 -41.79 68.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -69.4 -32.22 71.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 51.32 52.07 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.08 175.82 54.84 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -113.18 137.54 51.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 54.4 m 49.37 61.21 14.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.735 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.61 155.0 59.72 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.786 2.324 . . . . 0.0 111.931 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.13 -39.83 93.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.651 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.86 -44.03 82.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.5 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.38 -41.19 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.52 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -60.68 -34.62 74.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 55.2 65.59 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.09 -39.46 95.81 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -127.7 145.16 50.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.099 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 60.4 p -127.31 66.0 67.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 109.928 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.47 151.41 65.03 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.284 2.656 . . . . 0.0 112.506 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.88 -44.29 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.687 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -56.54 -43.46 79.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.592 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp -49.24 -29.01 5.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -64.51 -32.79 74.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -59.46 131.42 50.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.81 171.44 53.86 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 53.49 60.03 3.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.147 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.6 m -105.91 97.72 16.11 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.298 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.19 -175.94 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.715 2.277 . . . . 0.0 111.897 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.04 -39.58 90.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.574 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.85 -29.23 66.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.56 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.95 -41.01 17.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -69.77 -27.66 65.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 50.24 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.464 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 91.64 -10.9 73.57 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -104.43 -8.34 19.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.839 0.352 . . . . 0.0 110.499 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.419 ' N ' ' CD ' ' A' ' 714' ' ' PRO . 61.1 m -61.19 -41.31 79.82 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 713' ' ' SER . 86.0 Cg_exo -46.5 134.13 16.39 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.831 1.687 . . . . 0.0 113.286 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.96 154.09 32.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.355 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.177 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.711 0.291 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 696' ' ' ARG . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.416 ' CZ ' HD11 ' A' ' 692' ' ' LEU . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 701' ' ' VAL . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 701' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 697' ' ' ILE . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 679' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.818 0.342 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 695' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 699' ' ' PHE . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 695' ' ' LEU . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.795 0.331 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.809 0.338 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 695' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 699' ' ' PHE . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' PHE . . . . . 0.416 ' HE1' HD11 ' A' ' 695' ' ' LEU . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.655 0.264 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 708' ' ' VAL . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 705' ' ' VAL . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.826 0.346 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.697 0.284 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.734 0.302 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.817 0.342 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 695' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 699' ' ' PHE . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 695' ' ' LEU . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.524 -0.023 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.58 -48.01 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.53 -33.18 44.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 696' ' ' ARG . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.416 ' CZ ' HD11 ' A' ' 692' ' ' LEU . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 701' ' ' VAL . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 697' ' ' ILE . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -70.08 -37.97 75.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 55.4 35.63 25.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.78 -39.5 97.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -147.56 160.13 42.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 56.1 m -81.16 123.38 81.76 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.395 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.8 145.09 97.67 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.982 1.788 . . . . 0.0 112.178 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.95 -39.49 92.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.517 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -66.91 -40.9 87.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 679' ' ' LEU . 10.4 mp -74.26 -42.03 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.626 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 -67.69 -34.1 76.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -161.58 98.18 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.29 99.54 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -67.95 131.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.289 . . . . 0.0 110.788 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 91.7 p -140.12 160.19 61.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.97 145.53 97.11 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.823 2.349 . . . . 0.0 112.42 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 tp -107.47 122.7 47.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.161 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -71.27 -35.23 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.543 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt -51.5 -33.57 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.577 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 699' ' ' PHE . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 695' ' ' LEU . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -65.57 -32.26 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 54.26 61.88 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -155.84 177.25 33.04 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 54.42 39.71 31.22 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.8 m -59.28 -44.88 98.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.68 137.98 79.8 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.875 1.717 . . . . 0.0 113.771 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 8.1 mp 40.48 57.27 2.58 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.281 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.673 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 15.2 p30 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -75.63 -38.82 58.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.529 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.56 -41.03 28.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -64.79 -36.52 84.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 54.12 84.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.482 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 59.32 -132.44 52.0 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.837 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -110.3 21.46 16.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.763 -0.219 . . . . 0.0 111.261 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 22.1 t -127.41 73.57 77.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.63 61.64 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.323 2.682 . . . . 0.0 112.062 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 9.2 mp -101.51 139.34 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.636 ' CD1' HD11 ' A' ' 682' ' ' ILE . 40.3 t-105 -55.27 -32.2 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.07 -43.08 68.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 678' ' ' TRP . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 699' ' ' PHE . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' PHE . . . . . 0.416 ' HE1' HD11 ' A' ' 695' ' ' LEU . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -62.45 -37.7 86.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.33 136.36 49.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 65.6 -171.15 26.16 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 54.09 -88.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.4 t 51.19 67.48 4.22 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.04 145.88 97.36 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.706 2.271 . . . . 0.0 112.054 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 136.39 48.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.537 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.98 -45.88 69.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.472 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp -56.27 -37.07 69.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -65.45 -39.78 92.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -154.25 120.96 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.578 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.4 97.03 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' TYR . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 714' ' ' PRO . 93.4 t80 -126.68 114.01 17.44 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.307 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 714' ' ' PRO . 34.7 t -151.23 39.3 0.17 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 714' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 713' ' ' SER . 36.3 Cg_exo -60.36 137.46 74.65 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 CA-C-N 121.701 1.643 . . . . 0.0 110.456 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.1 mt -126.9 140.8 52.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.466 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.603 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -67.08 -43.78 81.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.584 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.05 -41.98 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.57 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 708' ' ' VAL . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 705' ' ' VAL . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.96 116.25 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.48 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -97.17 -21.84 19.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -155.8 156.92 35.61 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.588 0.232 . . . . 0.0 110.498 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 714' ' ' PRO . 1.3 m -104.62 -62.26 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.284 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 714' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 713' ' ' SER . 88.4 Cg_endo -78.66 158.46 28.36 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.949 1.766 . . . . 0.0 111.157 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 64.7 tp -101.92 121.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.677 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.52 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -53.69 -28.85 35.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.78 -42.67 57.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.616 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -70.64 -31.57 68.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -54.82 134.02 47.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 57.37 -132.21 52.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -148.97 158.86 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 72.4 m -78.27 147.61 72.91 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.999 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.53 -36.88 98.58 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.227 1.951 . . . . 0.0 112.109 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.67 -43.97 97.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.783 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.553 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -72.95 -29.33 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp -55.56 -35.27 65.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.25 -28.8 57.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -67.54 109.78 3.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -82.33 178.81 53.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -150.23 160.67 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 9.5 t 48.19 61.87 13.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.16 68.62 8.25 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.247 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.22 164.79 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.577 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -73.81 -37.35 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.456 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.32 -36.85 66.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.619 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -59.57 -40.1 86.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.32 118.24 6.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -110.46 17.7 28.26 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -146.2 161.54 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.2 t 51.54 61.65 12.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 153.67 57.66 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.861 2.374 . . . . 0.0 112.267 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.76 -39.51 94.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.595 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -71.59 -26.04 62.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.06 -41.41 61.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -64.45 -40.71 96.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 59.97 29.18 18.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 53.65 -127.23 36.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.551 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.42 141.17 51.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.049 0.452 . . . . 0.0 111.198 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 58.2 p -141.04 72.45 27.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.89 -68.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.464 2.109 . . . . 0.0 112.859 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 63.2 tp -142.31 128.94 20.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.538 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.444 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -61.06 -34.0 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.584 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.73 -41.79 68.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -69.4 -32.22 71.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 51.32 52.07 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.08 175.82 54.84 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -113.18 137.54 51.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 54.4 m 49.37 61.21 14.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.735 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.61 155.0 59.72 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.786 2.324 . . . . 0.0 111.931 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.13 -39.83 93.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.651 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.86 -44.03 82.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.5 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.38 -41.19 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.52 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 699' ' ' PHE . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 695' ' ' LEU . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -60.68 -34.62 74.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 55.2 65.59 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.09 -39.46 95.81 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -127.7 145.16 50.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.099 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 60.4 p -127.31 66.0 67.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 109.928 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.47 151.41 65.03 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.284 2.656 . . . . 0.0 112.506 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.88 -44.29 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.687 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -56.54 -43.46 79.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.592 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp -49.24 -29.01 5.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -64.51 -32.79 74.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -59.46 131.42 50.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.81 171.44 53.86 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 53.49 60.03 3.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.147 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.6 m -105.91 97.72 16.11 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.298 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.19 -175.94 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.715 2.277 . . . . 0.0 111.897 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.04 -39.58 90.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.574 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.85 -29.23 66.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.56 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.95 -41.01 17.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -69.77 -27.66 65.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 50.24 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.464 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 91.64 -10.9 73.57 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -104.43 -8.34 19.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.839 0.352 . . . . 0.0 110.499 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' SER . . . . . 0.419 ' N ' ' CD ' ' A' ' 714' ' ' PRO . 61.1 m -61.19 -41.31 79.82 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 713' ' ' SER . 86.0 Cg_exo -46.5 134.13 16.39 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.831 1.687 . . . . 0.0 113.286 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.96 154.09 32.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.355 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.177 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.711 0.291 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 696' ' ' ARG . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.416 ' CZ ' HD11 ' A' ' 692' ' ' LEU . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 701' ' ' VAL . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 697' ' ' ILE . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 679' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.818 0.342 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 699' ' ' PHE . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 695' ' ' LEU . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.795 0.331 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.809 0.338 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 699' ' ' PHE . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . 0.416 ' HE1' HD11 ' A' ' 695' ' ' LEU . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.655 0.264 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 708' ' ' VAL . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 705' ' ' VAL . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.826 0.346 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.697 0.284 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.734 0.302 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.817 0.342 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 699' ' ' PHE . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 695' ' ' LEU . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.524 -0.023 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.58 -48.01 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.53 -33.18 44.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -57.1 -49.05 77.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.572 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -65.86 -36.33 83.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.68 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -61.42 -45.26 95.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.55 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.1 -47.78 86.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.485 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -59.35 -42.09 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.01 -46.83 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.49 -41.77 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.492 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.27 -44.59 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.517 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.58 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.53 97.8 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -62.73 -43.21 99.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 696' ' ' ARG . 64.8 tp -62.03 -44.29 97.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.529 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.76 -42.64 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.69 -48.54 83.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.1 tp -54.27 -46.57 72.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.454 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.416 ' CZ ' HD11 ' A' ' 692' ' ' LEU . 2.1 mpt_? -59.72 -47.85 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.629 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 701' ' ' VAL . 90.3 mt -57.71 -46.01 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.629 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.37 -45.17 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.65 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.61 98.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.486 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 697' ' ' ILE . 54.1 t -61.23 -43.21 96.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.42 -42.75 95.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.751 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -58.87 -42.91 90.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.04 -43.39 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.56 -42.29 92.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.01 -45.03 90.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.581 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.44 -41.6 90.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -70.08 -37.97 75.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 55.4 35.63 25.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.78 -39.5 97.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -147.56 160.13 42.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 56.1 m -81.16 123.38 81.76 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.395 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.8 145.09 97.67 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.982 1.788 . . . . 0.0 112.178 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.95 -39.49 92.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.517 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -66.91 -40.9 87.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 679' ' ' LEU . 10.4 mp -74.26 -42.03 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.626 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -55.1 -49.58 71.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.74 -33.1 74.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 42.1 mt -65.09 -41.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.277 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.32 -45.36 91.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.441 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.4 mt -58.25 -47.38 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.26 -41.89 85.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.2 mt -61.3 -46.14 97.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.597 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.64 -40.56 88.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.49 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 14.9 mm -60.19 -45.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.5 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.41 -39.45 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.678 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.24 -41.05 98.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.01 -43.34 99.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.85 -42.31 95.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.492 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.49 -42.3 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.524 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.92 -48.97 80.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.77 -47.7 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -56.88 -48.98 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.31 -46.2 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.576 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.36 -46.8 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.28 -41.9 99.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.509 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.24 98.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.542 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.61 -43.53 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.461 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.49 -42.79 98.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.74 -42.6 97.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.78 -42.11 97.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.33 -44.88 99.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.595 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.34 -42.32 91.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -62.54 -46.73 87.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.31 -42.15 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.522 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 -67.69 -34.1 76.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.596 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -161.58 98.18 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.29 99.54 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -67.95 131.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.289 . . . . 0.0 110.788 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 91.7 p -140.12 160.19 61.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.97 145.53 97.11 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.823 2.349 . . . . 0.0 112.42 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 tp -107.47 122.7 47.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.161 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -71.27 -35.23 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.543 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 85.3 mt -51.5 -33.57 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.577 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -57.38 -48.3 79.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.608 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.52 -36.92 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.88 -42.85 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.508 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 -45.53 93.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.36 -48.36 82.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.635 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -59.21 -41.09 87.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.25 -47.1 95.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.02 -41.91 91.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 17.1 mm -59.44 -45.79 93.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.45 -43.01 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.631 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.39 98.9 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.39 -41.84 98.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.28 -41.89 91.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.563 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.93 -48.94 80.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 699' ' ' PHE . 64.0 tp -54.24 -45.65 72.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -60.57 -47.45 86.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.98 -46.0 87.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.616 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.78 -42.94 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.476 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 695' ' ' LEU . 6.1 m-85 -63.88 -43.24 96.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.449 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.57 99.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.52 -43.65 94.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.57 -43.32 97.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.4 p -60.74 -42.38 97.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.09 -41.76 97.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.677 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.6 -42.7 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.564 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.59 -41.6 90.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.456 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -64.15 -45.37 88.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.71 -41.41 90.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -65.57 -32.26 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 54.26 61.88 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -155.84 177.25 33.04 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 54.42 39.71 31.22 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.8 m -59.28 -44.88 98.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.68 137.98 79.8 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.875 1.717 . . . . 0.0 113.771 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 8.1 mp 40.48 57.27 2.58 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.281 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.673 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 15.2 p30 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -75.63 -38.82 58.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.529 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.56 -41.03 28.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -54.95 -49.13 72.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -67.47 -32.48 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.734 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.81 -43.38 96.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -62.78 -45.19 93.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.67 -47.0 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.82 -43.81 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.82 -46.31 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.5 mm -61.2 -44.16 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -57.09 -44.41 83.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.726 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.7 -47.41 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.0 97.03 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 91.2 p -61.57 -42.94 99.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.06 -42.25 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.04 -41.28 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.51 -47.21 86.4 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.74 -46.29 74.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.458 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -62.22 -46.07 90.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.581 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.5 mm -57.04 -45.57 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.77 -44.92 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.528 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -62.98 -41.33 99.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.46 -42.2 99.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.73 -44.46 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.401 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.51 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.4 m -61.78 -41.12 97.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.0 -42.63 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.53 -42.29 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -60.13 -42.49 94.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -62.89 -45.16 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -42.2 95.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -64.79 -36.52 84.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.548 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 54.12 84.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.482 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 59.32 -132.44 52.0 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.837 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -110.3 21.46 16.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.763 -0.219 . . . . 0.0 111.261 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 22.1 t -127.41 73.57 77.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.63 61.64 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.323 2.682 . . . . 0.0 112.062 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 9.2 mp -101.51 139.34 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.636 ' CD1' HD11 ' A' ' 682' ' ' ILE . 40.3 t-105 -55.27 -32.2 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.07 -43.08 68.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -56.12 -45.51 79.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.603 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -69.76 -34.38 73.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 678' ' ' TRP . 50.8 mt -63.86 -42.19 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.476 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.6 -45.05 92.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.27 -47.79 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.493 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.76 -41.43 91.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.96 -45.65 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 18.5 mm -60.6 -43.54 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.4 mt -57.91 -44.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.34 -42.81 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.41 99.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.51 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.01 -42.69 99.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 87.5 mt -61.58 -43.35 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.15 -46.67 90.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 699' ' ' PHE . 65.9 tp -55.42 -46.5 76.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.535 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -61.81 -45.87 91.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.591 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.67 -46.37 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.553 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.52 -42.57 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.509 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . 0.416 ' HE1' HD11 ' A' ' 695' ' ' LEU . 7.3 m-85 -63.65 -42.53 98.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.472 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.94 99.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.542 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.42 -44.84 97.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.8 -43.66 98.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.7 t -61.72 -41.75 98.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.3 tp -63.94 -42.14 97.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.49 -41.52 91.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.586 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.53 -41.78 90.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.479 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.92 -43.21 93.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.34 -43.16 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.485 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -62.45 -37.7 86.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.33 136.36 49.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 65.6 -171.15 26.16 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 54.09 -88.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.4 t 51.19 67.48 4.22 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.04 145.88 97.36 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.706 2.271 . . . . 0.0 112.054 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 136.39 48.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.537 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.98 -45.88 69.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.472 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.1 tp -56.27 -37.07 69.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.94 -48.05 76.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -67.67 -35.53 79.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.62 -44.97 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.446 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -61.56 -44.66 96.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.645 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.8 mm -58.39 -48.6 84.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -60.39 -41.01 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.9 mt -60.13 -45.24 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.48 -43.54 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.472 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.0 -43.44 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -44.08 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.657 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.01 -39.34 96.35 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -43.02 99.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.39 -44.07 97.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.78 -41.8 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.634 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.72 -51.16 60.65 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.4 mp -54.44 -46.22 73.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -60.25 -48.13 83.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.8 -46.23 87.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.13 -44.05 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.15 -43.46 98.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.23 95.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.98 -44.43 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.66 -44.08 94.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.556 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 91.6 p -60.56 -42.57 96.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.08 -41.74 97.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 63.6 t -64.99 -42.71 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.531 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.94 -41.83 92.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.11 -46.38 84.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.644 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.97 -41.96 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -65.45 -39.78 92.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -154.25 120.96 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.578 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.4 97.03 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 714' ' ' PRO . 93.4 t80 -126.68 114.01 17.44 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.307 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 714' ' ' PRO . 34.7 t -151.23 39.3 0.17 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 713' ' ' SER . 36.3 Cg_exo -60.36 137.46 74.65 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 CA-C-N 121.701 1.643 . . . . 0.0 110.456 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 88.1 mt -126.9 140.8 52.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.466 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.603 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -67.08 -43.78 81.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.584 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.05 -41.98 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.57 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -56.33 -48.22 77.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.534 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -68.57 -35.04 76.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.739 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 5.7 mm -64.72 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.42 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -63.46 -45.81 89.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.68 -47.39 85.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.524 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.67 -40.85 93.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.529 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 78.8 mt -61.59 -46.66 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.487 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.16 -41.89 93.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.565 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 81.6 mt -58.07 -42.89 84.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.592 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.18 -42.81 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.08 -40.49 99.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 95.3 p -61.58 -43.47 98.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.93 -42.63 94.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.436 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.71 -41.35 90.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.71 -47.25 85.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.23 -46.92 72.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.5 -45.96 91.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.22 -46.34 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.524 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.5 -44.92 85.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -63.25 -42.57 99.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.06 99.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.83 -44.0 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.67 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.64 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.8 m -63.22 -41.11 99.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.586 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.7 -42.06 98.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 708' ' ' VAL . 57.8 t -64.28 -42.1 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.06 -42.37 94.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.42 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.46 -44.92 93.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.635 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 705' ' ' VAL . 28.9 m -62.83 -43.09 98.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -67.37 -35.47 79.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -71.96 116.25 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.48 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -97.17 -21.84 19.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -155.8 156.92 35.61 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.588 0.232 . . . . 0.0 110.498 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 714' ' ' PRO . 1.3 m -104.62 -62.26 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.284 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 713' ' ' SER . 88.4 Cg_endo -78.66 158.46 28.36 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.949 1.766 . . . . 0.0 111.157 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 64.7 tp -101.92 121.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.677 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.52 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -53.69 -28.85 35.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.78 -42.67 57.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.616 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -54.65 -49.62 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.05 -33.97 75.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.9 mm -62.94 -42.72 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -63.41 -44.72 93.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.7 mm -57.22 -48.06 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.496 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.74 -42.49 88.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.85 -47.53 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.05 -43.6 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.602 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.63 -45.68 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.82 -41.06 99.58 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.89 -43.92 97.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -61.43 -43.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.699 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.67 -47.94 85.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 65.7 tp -54.97 -46.54 75.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.05 -45.97 92.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.546 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.69 -47.08 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.587 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.28 -43.64 82.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.427 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -63.11 -42.94 99.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.377 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.06 97.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.74 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.518 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.0 tp -62.64 -45.47 92.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.9 p -59.92 -42.11 93.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.496 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.88 -42.66 97.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.712 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.43 -43.71 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.93 -42.96 91.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -62.62 -45.07 94.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.511 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.542 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -70.64 -31.57 68.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -54.82 134.02 47.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 57.37 -132.21 52.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -148.97 158.86 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 72.4 m -78.27 147.61 72.91 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.999 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.53 -36.88 98.58 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.227 1.951 . . . . 0.0 112.109 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.67 -43.97 97.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.783 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.553 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -72.95 -29.33 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 64.0 tp -55.56 -35.27 65.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -57.82 -44.44 86.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -68.48 -36.17 78.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 21.7 mm -62.99 -43.41 99.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.59 -45.45 94.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.654 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 90.2 mt -58.28 -49.4 81.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -58.02 -42.05 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.19 -46.62 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.8 mt -61.01 -42.33 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.13 -45.6 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.05 -38.94 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.04 94.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.1 t -62.41 -44.13 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 65.0 tp -61.79 -44.78 96.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.3 mm -61.35 -43.03 95.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.2 81.79 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 82.3 mt -54.68 -45.72 73.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.541 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -59.34 -47.66 84.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.553 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.85 -46.01 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.649 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -45.04 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -63.33 -42.48 98.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.396 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.64 99.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.53 -43.34 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.26 -41.57 96.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.664 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 94.8 p -61.23 -42.07 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.517 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.96 -41.48 97.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.2 -43.11 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -59.88 -42.76 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.57 -45.78 88.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.26 -40.12 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.25 -28.8 57.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -67.54 109.78 3.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -82.33 178.81 53.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -150.23 160.67 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 9.5 t 48.19 61.87 13.08 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.16 68.62 8.25 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.247 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.22 164.79 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.577 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -73.81 -37.35 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.456 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.32 -36.85 66.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.619 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -57.96 -47.0 84.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.538 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -67.03 -36.12 81.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.651 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.15 -43.34 97.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.517 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.92 -45.64 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.54 -47.64 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -60.45 -42.05 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.612 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.13 -46.22 94.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.516 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.21 -42.3 89.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.474 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.29 -45.04 93.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.605 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.4 -41.73 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.569 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.68 95.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -62.29 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.713 0.292 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.36 -44.57 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.87 -42.99 98.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.522 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.17 59.94 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.29 -46.98 76.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.269 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -58.06 -49.1 78.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.69 -46.18 86.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.54 -44.61 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -62.94 -42.47 99.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.504 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.32 99.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.04 -42.5 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.93 -42.81 94.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.5 p -59.36 -42.84 92.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.91 -41.71 97.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.56 -42.71 97.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.92 -42.41 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.51 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -64.46 -44.74 90.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.577 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.1 -42.01 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -59.57 -40.1 86.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.551 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.32 118.24 6.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -110.46 17.7 28.26 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -146.2 161.54 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 8.2 t 51.54 61.65 12.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 153.67 57.66 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.861 2.374 . . . . 0.0 112.267 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.76 -39.51 94.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.595 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -71.59 -26.04 62.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.06 -41.41 61.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -55.17 -48.57 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.706 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -69.18 -33.16 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.16 -43.67 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -63.58 -43.97 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 19.4 mm -58.06 -47.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.47 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.96 -41.23 86.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.456 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 86.9 mt -61.66 -46.92 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.396 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 20.0 mm -61.98 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.39 -46.03 92.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.16 -43.34 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.46 -40.47 98.85 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.7 t -60.98 -41.74 97.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.628 0.252 . . . . 0.0 110.481 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -42.94 92.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.6 -41.87 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.699 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.44 -49.18 76.33 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.32 -47.37 75.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.416 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -60.65 -46.98 88.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 12.9 mm -57.8 -46.1 87.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.47 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 55.0 t -57.98 -44.75 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -61.24 -40.59 94.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.44 99.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.461 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.17 -43.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 64.1 tp -63.0 -43.43 98.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -62.99 -40.89 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.477 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.95 -43.44 95.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.08 -41.81 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.524 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.84 -43.07 98.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.44 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -44.47 96.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.677 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -42.81 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.502 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -64.45 -40.71 96.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 59.97 29.18 18.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 53.65 -127.23 36.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.551 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.42 141.17 51.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.049 0.452 . . . . 0.0 111.198 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 58.2 p -141.04 72.45 27.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.89 -68.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.464 2.109 . . . . 0.0 112.859 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 63.2 tp -142.31 128.94 20.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.538 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.444 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -61.06 -34.0 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.584 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.73 -41.79 68.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -56.66 -45.1 81.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -68.74 -33.37 73.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.588 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.91 -41.14 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -64.63 -45.31 87.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.76 -47.2 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.602 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.18 -42.21 94.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.494 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 81.0 mt -60.47 -45.74 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.9 mt -59.0 -45.07 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.6 mt -58.83 -45.44 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.57 -43.47 94.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.581 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.08 95.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 75.7 m -61.63 -45.11 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.33 . . . . 0.0 110.549 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.97 -42.82 99.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.537 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.0 -41.85 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.47 82.26 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 66.2 tp -54.86 -46.98 74.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.338 . . . . 0.0 110.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -59.89 -46.75 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.673 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 86.7 mt -57.29 -45.96 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.606 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.5 -45.91 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -61.47 -41.58 97.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.12 99.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.565 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.72 -43.89 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.67 -43.44 96.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.9 t -60.78 -42.17 97.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.506 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.22 -42.58 96.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.05 -43.21 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.533 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -43.36 95.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -62.5 -45.87 91.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.2 -41.88 91.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -69.4 -32.22 71.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.651 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 51.32 52.07 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.08 175.82 54.84 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -113.18 137.54 51.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 54.4 m 49.37 61.21 14.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.735 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.61 155.0 59.72 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.786 2.324 . . . . 0.0 111.931 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.13 -39.83 93.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.651 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.86 -44.03 82.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.5 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.38 -41.19 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.52 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -55.07 -49.49 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.587 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.93 -33.23 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.4 mt -64.17 -41.54 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.33 -45.29 88.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.598 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.97 -45.57 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -58.34 -44.09 88.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.21 -44.96 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.12 -44.4 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.549 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 20.2 mm -58.04 -46.5 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.17 -41.97 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.601 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.82 99.34 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.74 -42.63 99.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.491 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.78 -42.86 99.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.92 -42.05 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.99 -50.49 67.07 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 699' ' ' PHE . 61.3 tp -54.65 -47.76 73.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.467 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -58.86 -48.01 82.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.96 -46.35 83.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.35 -46.44 85.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.57 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 695' ' ' LEU . 23.4 m-85 -61.76 -42.76 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.495 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.36 99.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.488 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.52 -42.4 99.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.586 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 47.6 t -61.42 -41.53 97.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.73 -42.3 97.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.11 -43.73 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.552 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -63.85 -47.45 80.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.538 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.27 -42.73 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -60.68 -34.62 74.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.592 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 55.2 65.59 1.45 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.09 -39.46 95.81 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -127.7 145.16 50.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.099 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 60.4 p -127.31 66.0 67.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 109.928 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.47 151.41 65.03 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.284 2.656 . . . . 0.0 112.506 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.88 -44.29 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.687 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -56.54 -43.46 79.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.592 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 62.3 tp -49.24 -29.01 5.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -56.43 -50.04 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.42 -35.35 79.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 19.1 mm -63.21 -43.16 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.97 -44.73 96.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.94 -47.12 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.38 -42.24 86.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.532 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.92 -46.94 95.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.04 -42.77 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.39 -43.35 93.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.499 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.23 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.03 97.16 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 47.9 t -61.71 -43.46 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.7 -43.76 95.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.03 -43.2 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.43 88.63 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 81.2 mt -54.4 -46.43 73.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -59.94 -46.94 87.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 89.5 mt -58.65 -46.53 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.542 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.0 -44.96 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.25 -43.01 99.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.75 96.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.369 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.82 -42.65 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.38 -43.45 94.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.611 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 74.9 m -59.5 -43.42 93.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.564 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 64.6 tp -63.71 -42.54 97.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.43 -44.06 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -60.69 -42.27 96.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -63.15 -44.02 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.545 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.61 -41.63 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -64.51 -32.79 74.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -59.46 131.42 50.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -80.81 171.44 53.86 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 53.49 60.03 3.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.147 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 49.6 m -105.91 97.72 16.11 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.298 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.19 -175.94 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.715 2.277 . . . . 0.0 111.897 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.04 -39.58 90.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.574 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -69.85 -29.23 66.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.56 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.95 -41.01 17.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -55.31 -47.29 75.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -70.8 -33.99 71.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.06 -42.1 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.468 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.51 -43.98 83.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 89.6 mt -57.26 -47.11 84.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.65 -46.03 96.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.427 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.46 -43.79 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.73 -43.73 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.07 -44.74 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.83 -40.36 98.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 48.3 t -61.07 -44.43 97.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 0.0 110.466 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.19 -42.72 99.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.79 -43.28 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.41 -46.83 91.73 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.0 tt -55.13 -46.81 75.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.431 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -60.66 -45.88 92.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 87.5 mt -58.06 -47.01 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.561 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.06 -42.97 99.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.49 98.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.524 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.24 -45.62 95.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.584 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 73.7 m -60.75 -42.39 97.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.428 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.09 -42.41 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.41 -44.6 99.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.66 -43.09 94.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.572 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.98 -46.73 87.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.44 -42.41 93.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -69.77 -27.66 65.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 50.24 -172.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.464 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . 91.64 -10.9 73.57 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -104.43 -8.34 19.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.839 0.352 . . . . 0.0 110.499 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . 0.419 ' N ' ' CD ' ' A' ' 714' ' ' PRO . 61.1 m -61.19 -41.31 79.82 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 713' ' ' SER . 86.0 Cg_exo -46.5 134.13 16.39 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.831 1.687 . . . . 0.0 113.286 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.96 154.09 32.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.355 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.177 -179.86 . . . . . . . . 1 1 . 1 stop_ save_